Exact Sciences stock crumbled Thursday on its growing rivalry with Guardant Health and Natera in colon cancer screening.
Despite the availability of several noninvasive tests for colorectal cancer, prioritizing blood-based tests may result in ...
Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in ...
Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a ...